Improved protection of mice against lethal respiratory infection with Coccidioides posadasii using two recombinant antigens expressed as a single protein.
暂无分享,去创建一个
J. Galgiani | T. Kirkland | J. Simons | G. Cole | C. Hung | J. Xue | Jieh-Juen Yu | R. Herr | L. Shubitz | T. Peng | Robert Perrill | Jianmin Xue
[1] D. Rhee,et al. Comparison of the rabbit pyrogen test and Limulus amoebocyte lysate (LAL) assay for endotoxin in hepatitis B vaccines and the effect of aluminum hydroxide. , 2005, Biologicals : journal of the International Association of Biological Standardization.
[2] G. Cole,et al. Immune response of vaccinated and non-vaccinated mice to Coccidioides posadasii infection. , 2005, Vaccine.
[3] M. Kataoka,et al. Endotoxin content in Haemophilus influenzae type b vaccine. , 2004, Japanese journal of infectious diseases.
[4] G. Cole,et al. A Recombinant β-1,3-Glucanosyltransferase Homolog of Coccidioides posadasii Protects Mice against Coccidioidomycosis , 2003, Infection and Immunity.
[5] T. Liang,et al. Hepatitis C virus–like particles combined with novel adjuvant systems enhance virus‐specific immune responses , 2003, Hepatology.
[6] Suzanne M Johnson,et al. In Vitro Whole-Blood Analysis of Cellular Immunity in Patients with Active Coccidioidomycosis by Using the Antigen Preparation T27K , 2002, Clinical and Vaccine Immunology.
[7] J. Galgiani,et al. Localization within a Proline-Rich Antigen (Ag2/PRA) of Protective Antigenicity against Infection with Coccidioides immitis in Mice , 2002, Infection and Immunity.
[8] D. Magee,et al. Role of Signal Sequence in Vaccine-Induced Protection against Experimental Coccidioidomycosis , 2002, Infection and Immunity.
[9] U. Reichard,et al. A Parasitic Phase-Specific Adhesin of Coccidioides immitis Contributes to the Virulence of This Respiratory Fungal Pathogen , 2002, Infection and Immunity.
[10] J. Galgiani,et al. Protection of Mice against Coccidioides immitis Intranasal Infection by Vaccination with Recombinant Antigen 2/PRA , 2002, Infection and Immunity.
[11] D. Geier,et al. Clinical Implications of Endotoxin Concentrations in Vaccines , 2002, The Annals of pharmacotherapy.
[12] T. White,et al. Molecular and phenotypic description of Coccidioides posadasii sp. nov., previously recognized as the non-California population of Coccidioides immitis , 2002, Mycologia.
[13] G. Cole,et al. Recombinant Urease and Urease DNA ofCoccidioides immitis Elicit an Immunoprotective Response against Coccidioidomycosis in Mice , 2001, Infection and Immunity.
[14] G. Cole,et al. Cloning and Expression of the Gene Which Encodes a Tube Precipitin Antigen and Wall-Associated β-Glucosidase ofCoccidioides immitis , 2001, Infection and Immunity.
[15] D. Pappagianis,et al. Seeking a vaccine against Coccidioides immitis and serologic studies: expectations and realities. , 2001, Fungal genetics and biology : FG & B.
[16] Paul L. Williams,et al. Practice Guidelines for the Treatment of Coccidioidomycosis , 2000 .
[17] J. J. Yu,et al. Sequence, expression and functional analysis of the Coccidioides immitis ODC (ornithine decarboxylase) gene. , 2000, Gene.
[18] D. Magee,et al. Coadministration of Interleukin 12 Expression Vector with Antigen 2 cDNA Enhances Induction of Protective Immunity againstCoccidioides immitis , 1999, Infection and Immunity.
[19] J. Galgiani,et al. Resistance to Coccidioides immitis in Mice after Immunization with Recombinant Protein or a DNA Vaccine of a Proline-Rich Antigen , 1999, Infection and Immunity.
[20] D. Magee,et al. Genetic Vaccination against Coccidioides immitis: Comparison of Vaccine Efficacy of Recombinant Antigen 2 and Antigen 2 cDNA , 1999, Infection and Immunity.
[21] N. Ampel,et al. Coccidioidomycosis in Arizona: increase in incidence from 1990 to 1995. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[22] J. Galgiani,et al. Evaluation of the Proline-Rich Antigen ofCoccidioides immitis as a Vaccine Candidate in Mice , 1998, Infection and Immunity.
[23] Suzanne M Johnson,et al. Protection against Lethal Murine Coccidioidomycosis by a Soluble Vaccine from Spherules , 1998, Infection and Immunity.
[24] T. Kirkland,et al. Immunogenicity of a 48-Kilodalton Recombinant T-Cell-Reactive Protein of Coccidioides immitis , 1998, Infection and Immunity.
[25] K. Jansen,et al. Human papillomavirus type 11 (HPV-11) neutralizing antibodies in the serum and genital mucosal secretions of African green monkeys immunized with HPV-11 virus-like particles expressed in yeast. , 1997, The Journal of infectious diseases.
[26] T. Kirkland,et al. Isolation and characterization of the urease gene (URE) from the pathogenic fungus Coccidioides immitis. , 1997, Gene.
[27] D. Magee,et al. Coccidioides immitis antigen 2: analysis of gene and protein. , 1996, Gene.
[28] N. Ampel,et al. Cytokine production by peripheral blood mononuclear cells in human coccidioidomycosis. , 1996, The Journal of infectious diseases.
[29] J. H. Law,et al. Cloning and sequence analysis of the cDNA for a protein from Coccidioides immitis with immunogenic potential. , 1996, Biochemical and biophysical research communications.
[30] G. Cole,et al. Molecular and biochemical characterization of a Coccidioides immitis-specific antigen , 1995, Infection and immunity.
[31] B. Zimmer,et al. Serology of coccidioidomycosis , 1990, Clinical Microbiology Reviews.
[32] A. Garg,et al. Evaluation of commercial reagents to identify the exoantigens of Blastomyces dermatitidis, Coccidioides immitis, and Histoplasma species cultures. , 1984, American journal of clinical pathology.
[33] B. W. Brown,et al. Immunologic responsiveness and safety associated with the Coccidioides immitis spherule vaccine in volunteers of white, black, and Filipino ancestry. , 1984, American journal of epidemiology.
[34] P. Standard,et al. Evaluation of a commercial exoantigen test system for the rapid identification of systemic fungal pathogens. , 1983, American journal of clinical pathology.
[35] G. Land,et al. Evaluation of the exoantigen test for identification of Histoplasma species and Coccidioides immitis cultures , 1980, Journal of clinical microbiology.
[36] S. Sun,et al. Specificity of exoantigens for identifying cultures of Coccidioides immitis , 1978, Journal of clinical microbiology.
[37] L. Kaufman,et al. Improved version of the exoantigen test for identification of Coccidioides immitis and Histoplasma capsulatum cultures , 1978, Journal of clinical microbiology.
[38] Y. Kong,et al. IMMUNIZATION OF MICE TO COCCIDIOIDES IMMITIS: DOSE, REGIMEN AND SPHERULATION STAGE OF KILLED SPHERULE VACCINES. , 1965, Journal of immunology.
[39] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[40] C. Smith,et al. Pattern of 39,500 serologic tests in coccidioidomycosis. , 1956, Journal of the American Medical Association.
[41] K. Blennow,et al. Identification of proteins in a human pleural exudate using two‐dimensional preparative liquid‐phase electrophoresis and matrix‐assisted laser desorption/ionization mass spectrometry , 1999, Electrophoresis.
[42] M. Rosolowsky,et al. Vaccination with yeast-expressed cottontail rabbit papillomavirus (CRPV) virus-like particles protects rabbits from CRPV-induced papilloma formation. , 1995, Vaccine.